Search

Your search keyword '"Dangel, Oliver"' showing total 3 results
Start Over Author "Dangel, Oliver" Publication Year Range Last 3 years
3 results on '"Dangel, Oliver"'

2. Comparison of the real-world safety of two different long-acting methylphenidate formulations (Medikinet® MR and Concerta®) – a Danish nationwide register-based cohort study

Author

Ørnberg Jakob, Mayer Anke, Dangel Oliver, and Ammer Richard

Subjects
methylphenidate, real-world safety, adverse events, attention-deficit hyperactivity disorder, register study, Psychiatry, RC435-571, Psychology, BF1-990
Abstract

Medikinet® MR and Concerta® are long-acting methylphenidate formulations used for the treatment of pediatric and adult attention-deficit/hyperactivity disorder (ADHD). The two formulations have shown comparable safety profiles in two head-to-head randomized controlled trials. However, real-world studies comparing the safety profiles of these products are not available.

Published
2024
Full Text
View/download PDF

3. Pharmacokinetics of a Modified-Release Dexamphetamine Sulfate Formulation Following Single and Multiple Dosing in Healthy Adults: Comparative Bioavailability with Immediate-Release Dexamphetamine Sulfate, between Strengths, Assessment of Food and Meal Composition Effects

Author

Sandersleben Henrik Uebel-von, Mayer Anke, Ruhmann Michaela, Dangel Oliver, and Schütz Helmut

Subjects
adhd, dexamphetamine, comparative bioavailability, pharmacokinetic study, Psychiatry, RC435-571, Psychology, BF1-990
Abstract

A modified-release dexamphetamine sulfate formulation (DEX-MR) is under development for the treatment of attention-deficit/hyperactivity disorder.

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results